Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen.

MLA

Bognàr, T., et al. “Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen.” Transplantation and Cellular Therapy, vol. 30, no. 10, Oct. 2024, p. 1007.e1-1007.e10. EBSCOhost, https://doi.org/10.1016/j.jtct.2024.07.015.

APA

Bognàr, T., Bartelink, I. H., van der Elst, K. C. M., Kingma, J. S., Smeijsters, E. H., Lindemans, C. A., Egberts, A. C. G., Kuball, J. H. E., de Witte, M. A., Schultink, A. H. M. de V., & Lalmohamed, A. (2024). Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen. Transplantation and Cellular Therapy, 30(10), 1007.e1-1007.e10. https://doi.org/10.1016/j.jtct.2024.07.015

Chicago

Bognàr, T, I H Bartelink, K C M van der Elst, J S Kingma, E H Smeijsters, C A Lindemans, A C G Egberts, et al. 2024. “Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen.” Transplantation and Cellular Therapy 30 (10): 1007.e1-1007.e10. doi:10.1016/j.jtct.2024.07.015.